Healthtech Startups
16,917 companies tagged Healthtech, with their investors and founders.
Orbem uses AI-powered MRI technology to analyze biological materials and provide detailed insights to customers in agriculture and food production. The platform reveals internal characteristics of items like eggs and avocados to reduce waste and increase supply chain transparency.
3 investors
A pharmaceutical company developing therapeutics across oncology, hematology, neuroscience, immunology, and cardiovascular disease with a pipeline of 50 compounds targeting 40+ disease areas.
3 investors
Orbital RX provides a software platform for hospital pharmacy supply chain management that integrates inventory tracking, procurement workflows, and real-time team collaboration to coordinate shortage response across healthcare networks.
3 investors
Orbus Therapeutics is a clinical-stage biopharmaceutical company developing eflornithine (DFMO), an oral ODC inhibitor, as a cancer therapy. Its lead candidate targets recurrent grade 3 IDH-mutant astrocytoma and other cancers with ODC overexpression.
3 investors
Currax Pharmaceuticals develops and markets a portfolio of therapies for chronic progressive diseases. The company works within the healthcare and pharmaceutical industry to address patient health challenges.
3 investors
OrganoidSciences develops organoid-based regenerative therapeutics and evaluation solutions, operating dedicated GMP manufacturing facilities for cell/organoid drug production. Its lead program ATORM-C is an organoid therapy for inflammatory bowel disease, with clinical development across Korea, the US, and Europe.
3 investors
Ori Biotech develops manufacturing automation platforms for cell and gene therapies, addressing scalability and cost barriers that limit patient access to these treatments.
3 investors
Oricell Therapeutics (εε―ηη©) is a clinical-stage biopharmaceutical company developing cell therapies, including CAR-T products targeting GPRC5D for relapsed/refractory multiple myeloma and GPC3 for advanced liver cancer. Based in Shanghai, it builds proprietary antibody and CAR platforms (OriAb, OriCAR) to create cancer immunotherapies for unmet oncology needs such as liver, gastric, pancreatic, biliary, and ovarian cancers.
3 investors
Origin provides pelvic floor physical therapy for women and individuals with vaginal anatomy through in-clinic and virtual care. The company operates 20 clinics across the U.S. and delivers specialized treatment for conditions like postpartum recovery, menopause, and pelvic pain.
3 investors
Origin provides in-home pediatric speech, occupational, and physical therapy, connecting families with local licensed therapists and offering insurance-covered sessions. The company also serves therapists by letting them set their own schedules, choose clients, and build flexible caseloads.
3 investors
OrthAlign develops medical device technology for precise alignment during hip and knee replacement surgery, serving orthopedic surgeons in the surgical technology space.
3 investors
OS Benefits provides affordable health insurance and wellness benefits designed specifically for the hospitality industry, targeting independent restaurant and hospitality business owners seeking to provide employee healthcare coverage at sustainable costs.
3 investors
Osara Health (formerly CancerAid) provides evidence-based education, support and behavior-change programs for people impacted by cancer, including patients and caregivers, with the aim of improving clinical outcomes such as quality of life, physical and mental health, and survival rates. Founded in 2016 by oncologists, it operates as a global organization with Australian roots.
3 investors
Osigu provides an API-based platform serving the healthcare sector across Latin America and the US. The page offers limited detail beyond its developer API and office locations.
3 investors
OSSIO develops OSSIOfiber, a bio-integrative bone fixation implant material made from natural mineral fibers that provides stability during healing and integrates fully into bone over 18-24 months, avoiding permanent metal hardware. The implants are used in orthopedic surgical procedures such as hammertoe and other bone-healing treatments.
3 investors
OSSTEC is a medical device startup developing a 3D-printed biomimetic knee implant intended for use in hospitals. Founded out of Imperial College London, the company focuses on orthopedic implants aimed at improving patient mobility and quality of life.
3 investors
Ouihelp is a home care service that connects elderly and disabled people with qualified caregivers (auxiliaires de vie) to help them remain living at home, handling daily tasks such as personal hygiene, meal preparation, housekeeping, night care, and companionship. Operating in France under a mandataire model, it manages caregiver recruitment and care coordination, with services eligible for a 50% tax credit and public assistance such as the APA.
3 investors
Ouro Medicines is a biotechnology company developing cell-depleting therapies aimed at resetting the immune system to treat chronic immune-mediated diseases such as autoimmune and autoinflammatory conditions. It is advancing a pipeline of biologics and small molecules across immunology and related therapeutic areas.
3 investors
Outcomes4Me is an AI-driven patient platform that integrates with NCCN clinical oncology guidelines to provide personalized cancer care guidance, treatment options, clinical trial recommendations, and genetic testing information. The platform serves cancer patients directly by offering decision support tools and health data management to improve treatment access and outcomes.
3 investors
Override develops digital health solutions for treating chronic pain. The company aims to transform pain care delivery and improve outcomes for patients with chronic pain conditions.
3 investors
OxiWear develops a wearable device that monitors blood oxygen levels in patients with chronic conditions, designed to enable safe and independent daily living. The product was created by the CEO in collaboration with doctors at Johns Hopkins Hospital to address lifestyle challenges faced by patients at risk of low blood oxygen.
3 investors
Ozette runs a vertically integrated, AI-enabled lab and platform that generates high-dimensional spectral cytometry data and analyzes it to produce reproducible biomarker endpoints for clinical trials. It serves biopharma clinical development teams, discovery/R&D groups, and academic labs, operating under a validated (GCLP-compliant) quality system.
3 investors
Pager Health provides a white-label care navigation platform that combines AI with clinicians to help members find, access, and stay engaged with healthcare. It is offered to health plans as SaaS or a fully-staffed solution, covering care navigation, engagement, virtual health, and wellbeing.
3 investors
Panakeia develops software for biomarker profiling aimed at making precision diagnostics faster and instrument-free, to inform cancer diagnosis, treatment, and drug development. Its solutions target clinicians and researchers working in precision medicine and oncology.
3 investors